Upper gastrointestinal haemorrhage in emergency departments in France: Causes and management

European Journal of Emergency Medicine

Volumn 10, Issue 4, 2003, Pages 290-295

  Chassaignon, Cécile ^a   Letoumelin, Philippe ^b,c   Pateron, Dominique ^a,c  

^a HÔPITAL JEAN VERDIER   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS 13   (France)

Author keywords

Cirrhosis; Digestive haemorrhage; Emergency; Endoscopy; Non steroidal anti inflammatory drugs

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; ENDOSCOPY; EPIDEMIOLOGY; FEMALE; FIBROSIS; FOLLOW UP; FRANCE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PATIENT REFERRAL; PROSPECTIVE STUDY; STATISTICS; SURVIVAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CAUSALITY; COMORBIDITY; EMERGENCY SERVICE, HOSPITAL; ENDOSCOPY; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; FRANCE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; SURVIVAL ANALYSIS;

EID: 2442560588     PISSN: 09699546     EISSN: 14735695     Source Type: Journal    
DOI: 10.1097/00063110-200312000-00010     Document Type: Article

References (35)

1. Johnston SJ, Jones PF, Kyke J. Epidemiology and course of gastrointestinal haemorrhage in North-East Scotland. BMJ 1973; 3:655-660.
2. Blatchford O, Davidson LA, Murray WR, et al. Acute upper gastrointestinal bleeding in West of Scotland: a case ascertainment study. BMJ 1997; 315:510-514.
3. Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding. Gastoenterology 1983; 84:538-543.
4. Friedman LS, Martin P. The problem of gastrointestinal bleeding. Gastroenterol Clin North Am 1993; 22:717-722.
5. Czernichow P, Hochain P, Nousbaum JB, et al. Epidemiology and course of acute upper gastrointestinal haemorrhage in four French geographical areas. Eur J Gastoenterol Hepatol 2000; 12:175-181.
6. Amouretti M, Czernichow P, Kerjean A, et al. Prise en charge des hémorragies digestives hautes communautaires. Gastroenterol Clin Biol 2000; 24:1003-1011.
7. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
8. Escorsell A, Del Arbol LR, Planas R, et al. Multicenter randomized controlled trial of terlipressin versus sclerotherapy in the treatment of acute variceal bleeding: the TEST Study. Hepatology 2000; 32:471-476.
9. Garcia-Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343:769-772.
10. Carson JL, Strom BL, Morse L, et al. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med 1987; 147:1054-1059.
11. Hernandez-Diaz S, Garcia Rodriguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation. Arch Intern Med 2000; 160:2093-2099.
12. Laporte JR, Carne X, Vidal X, et al. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Lancet 1991; 337:85-89.
13. Recommandations pour la pratique clinique: remplissage vasculaire au cours des hypovolémies relatives ou absolues. Quels sont les critères diagnostiques d’une hypovolémie nécessitant un remplissage vasculaire? Rean Urg 1997; 3:347-360.
14. Laine L, Peterson W. Bleeding peptic ulcer. N Engl J Med 1994; 331:717-727.
15. Bourienne A, Pagenault M, Heresbach D, et al. Etude prospective multicentrique des facteurs pronostiques des hémorragies ulcéreuses gastroduodénales. Gastroentérol Clin Biol 2000; 24:193-200.
16. Lau JY, Sung JJ, Lam YH, et al. Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcers. N Engl J Med 1999; 340:751-756.
17. Sugawa C, Steffes CP, Nakamura R, et al. Upper GI bleeding in a urban hospital. Etiology, recurrence and pronostic. Ann Surg 1990; 212:521-527.
18. Levacher S, Letoumelin P, Pateron D, et al. Early administration of terlipressin plus trinitrin to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346:865-868.
19. D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999; 19:475-505.
20. Poynard T, Chaput JC, Mary JY, et al. Analyse critique des facteurs liés à la mortalité au trentième jour dans les hémorragies digestives hautes du cirrhotique. Gastroenterol Clin Biol 1980; 4:655-665.
21. Somerville K, Faulkner G, Langman M. Non steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet 1986; 1:462-464.
22. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987; 28:527-532.
23. Avage RL, Moller PW, Ballantyne CL, et al. Variation in the risk of peptic ulcer complications with nonsteroidal anti-inflammatory drug therapy. Arthr Rheum 1993; 36:84-90.
24. Henry D, Lim LLY, Garcia Rodriguez AG, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996; 312:1563-1566.
25. Kaufman DW, Kelly JP, Sheehan JE, et al. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding. Clin Pharmacol Ther 1993; 53:485-494.
26. Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med 2000; 343:834-839.
27. Savage RL, Moller PW, Ballantyne CL, et al. Variation in the risk of peptic ulcer complications with nonsteroidal anti-inflammatory drug therapy. Arthr Rheum 1993; 36:84-90.
28. Gabriel SE, Jaakkimainen L, Bombardier L. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 105:1078-1088.
29. De Ledinghen V, Heresbach D, Fourdain O, et al. Anti-inflammatory drugs and variceal bleeding: a case-control study. Gut 1999; 44:270-273.
30. De Franchis R. Upstanding consensus in portal hypertension: report of Baveno III consensus workshop on definitions, methodology, and therapeutic strategies in portal hypertension. J Hepatol 2000; 33:846-852.
31. Bernades P, Belghiti J, Bleichner G. et al. Les traitements d’urgence des hémorragies digestives hautes de l’hypertension portale de la cirrhose. Réunion de consensus, rapport final de la conférence, Paris, Novembre 1989. Gastroenterol Clin Biol 1990; 14:63B-67B.
32. Hadengue A. Somatostatin or octreotide in acute variceal bleeding. Digestion 1999; 60 (Suppl. 2):31-41.
33. Millat B, Hay JM, Valleur P, et al. French associations for surgical research. Emergency surgical treatment for bleeding ulcer: oversewing plus vagotomy versus gastric resection, a controlled randomized trial. World J Surg 1993; 17:568-574.
34. Rockall TA, Logan RFA, Devlin HB, et al. Variations in outcome after acute upper gastrointestinal hemorrhage. Lancet 1995; 346:346-350.
35. Lesur G, Artru P, Mitry E. Hémorragies digestives ulcéreuses: histoire naturelle et place de l’hémostase endoscopique. Gastroenterol Clin Biol 2000; 24:656-666.